No profile data available.
InterCure Ltd. (INCR) is an essential consumer products company in the marijuana product manufacturing industry, based in Herzliya, Israel, with about 320 full-time employees.
It reported revenue of 270.20 million ILS for fiscal year 2025, up 13.1% from fiscal year 2024, and net income of -35.71 million ILS. Its market capitalization was $72.73 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.
InterCure reported 270.20 million ILS in revenue for fiscal year 2025, up 13.1% from 238.85 million ILS in fiscal year 2024.
$72.73 million as of December 4, 2025.
Listed companies of a similar size in the same industry (marijuana product manufacturing) include Cresco Labs Inc. (CRLBF), Organigram Global Inc. (OGI), SciSparc Ltd. (SPRC), Healthier Choices Management Corp. (HCMC).